標題: 牙齒產業……DENTSPLY international (美股 XRAY)
Curry
同學




UID 66927
精華 0
積分 0
帖子 1522
閱讀權限 99
註冊 2017-2-14
用戶註冊天數 2599
用戶失蹤天數 408

118.163.167.118
發表於 2018-2-6 16:34  資料 私人訊息 
植牙&假牙排名:
Straumann Group最大(23%) (瑞士  STMN , 美股 SAUHY,SAUHF )Danaher第二(19%) ( 美股 DHR )(前兩名已佔約四成,且前兩名相差不大)
Zimmer Biomet (NYSE: ZBH)第三(10%)Dentsply Sirona Inc. (NASDAQ: XRAY)第四(7%)(後面兩相差不大)

依據Straumann Group – 2016 Annual Report來源
https://www.straumann.com/content/dam/media-center/group/en/documents/annual-report/2016/Markets.pdf


另外文章說明:
Institut Straumann AG (Switzerland), Danaher Corporation (U.S.), and DENTSPLY Sirona (U.S.) Dominated the Global Dental Implants Market

https://www.marketsandmarkets.com/ResearchInsight/dental-implants-prosthetics-market.asp

Theglobal dental implants market is consolidated in nature. The market isdominated by Danaher Corporation (U.S.), DENTSPLY Sirona (U.S.), InstitutStraumann AG (Switzerland), Zimmer Biomet Holdings Inc. (U.S.), and 3M Company(U.S.). The dominance of the above companies can be attributed to their widegeographic footprints, strong product portfolios, and large established clientbases. The rest of the market is fragmented in nature with the presence of manylocal and regional players.
Institut Straumann AG (Switzerland) was the leading market playerin the dental implants market in 2015. The company manufactures and developsdental prosthetics, dental implants, instruments, and tissue regenerationproducts that are primarily used in tooth replacement and restoration. Thecompany has a strong presence in over 70 countries globally, and its productsand services are available through a wide network of distribution subsidiariesand partners. Institut Straumann AG primarily focuses on strengthening itsdental implants and prosthetics portfolio and aims to maintain customersatisfaction by providing technologically advanced products and services, andtimely responses and resolutions to customer needs. The company significantlyinvests in R&D to drive innovation and in sales & marketing activitiesto capture growth potential in underpenetrated markets. In order to increaseits customer base and maintain its position in the dental implants andprosthetics market, the company focuses on various growth strategies such asacquisitions, agreements, and new product launches.
Danaher Corporation (U.S.) held the second-largest share in thedental implants market in 2015. The company has a strong presence across NorthAmerica, Europe, Australia, and Asia, with manufacturing facilities located inNorth America, South America, Europe, and Asia for its dental care business.The company has a diversified revenue system, which helps it to sustain itsleading position in the market. To garner the leading position in dental implantsand prosthetics market, the company focuses on acquisition and new productlaunches. For instance, in December 2014, the company acquired Nobel BiocareHolding AG (Switzerland), a global dental implants and prosthetics solutionscompany. This enabled Danaher to combine Nobel Biocare’s expertise in implantand dental prosthetics with its capabilities in 3D imaging, scanners, anddigital restorative solutions, enabling optimization in clinical workflows.
DENTSPLY Sirona was the third-largest player in the dentalimplants market in 2015. The company is mainly engaged in manufacturing ofCAD/CAM, imaging systems, and dental specialty products for endodontics,orthodontics, and implants. DENTSPLY Sirona Inc. has a strong presence in theU.S. and operates in around 120 countries across Europe; North, Central, andSouth America; South Africa; and the Pacific Rim. The company has adoptedmergers and acquisitions as its major growth strategy. For instance, inFebruary 2016, DENTSPLY International Inc. (U.S.) merged with Sirona DentalSystems, Inc. (U.S.). The merger helped the company in offering a powerful setof complementary products in the dental market.
Industry players adopted various strategies to achieve growth inthe dental implants and prosthetics market; however, the major strategy usedbetween 2013 and 2016 to achieve growth globally was new product launches. InJune 2016, Nobel Biocare, a subsidiary of Danaher Corporation (U.S.) launchedthe Locator R-Tx, a removable denture attachment system. In addition, in March2016, Zimmer Biomet Holdings, Inc. (U.S.) launched the new 3.1 mmD EzteticImplant. Partnerships, agreements, and collaborations were the other strategiesadopted by the top players in the dental implants and prosthetics market. Forinstance, in June 2016, DENTSPLY Sirona Inc. (U.S.) acquired MIS ImplantsTechnologies Ltd. (Israel), a dental implant systems manufacturer.


[ 本帖最後由 Curry 於 2018-2-6 16:43 編輯 ]
頂部
bkuo
同學




UID 1307
精華 0
積分 0
帖子 25
閱讀權限 99
註冊 2012-2-16
用戶註冊天數 4424
用戶失蹤天數 1828
來自 somewhere

36.228.99.76
發表於 2018-2-7 05:05  資料 私人訊息 
謝謝kaka桑以及Curry桑的資訊, 種牙有感, 相信是好果樹一顆, 希望這回能夠等到一個好價格入手.




[ 本帖最後由 bkuo 於 2018-2-7 05:15 編輯 ]
頂部
Curry
同學




UID 66927
精華 0
積分 0
帖子 1522
閱讀權限 99
註冊 2017-2-14
用戶註冊天數 2599
用戶失蹤天數 408

118.163.167.118
發表於 2018-2-7 10:11  資料 私人訊息 
昨天看牙齒有再請教牙醫同鞋,在牙齒產業除了植牙&假牙是否還有其他利基產品(講白了就是比較賺錢的),她有提到隱適美(隱形矯正牙套)ALGN,但ALGN的營收才XRAY的一半,且隱適美是進幾年才流行的產品,另外隨ALGN的利基產品隱適美專利到期牙材巨怪(Straumann Group (瑞士  STMN , 美股 SAUHY,SAUHF )、Danaher ( 美股 DHR )、Zimmer Biomet (NYSE: ZBH)、Dentsply Sirona Inc.)陸續進入隱適美產業,ALGN可能會被併或是GG。


總結:
牙材產業最主要就是看植牙&假牙廠商,牙醫同鞋昨天提到這兩個產品是從她在醫學院就一直在學,只是技術不斷演進,所以看得出這兩個利基產品在牙材產業是不變的,而Straumann Group、Danaher、Zimmer Biomet、Dentsply Sirona Inc.,這四家我比較推薦買Danaher,因Straumann Group及Danaher兩家其實在伯仲之間,但相較之下Danaher較穩,而Zimmer Biomet及Dentsply Sirona Inc.兩家加起來還不及Danaher,若Danaher能併Zimmer Biomet及Dentsply Sirona Inc.兩者其中一個那就更棒了!





頂部
Curry
同學




UID 66927
精華 0
積分 0
帖子 1522
閱讀權限 99
註冊 2017-2-14
用戶註冊天數 2599
用戶失蹤天數 408

118.163.167.118
發表於 2018-2-7 10:13  資料 私人訊息 
先前對ALGN的分析連結:ALGN
頂部
lounge19
同學




UID 2566
精華 0
積分 0
帖子 40
閱讀權限 99
註冊 2013-6-26
用戶註冊天數 3928
用戶失蹤天數 2005

59.120.153.200
發表於 2018-2-8 10:12  資料 私人訊息 
請教Curry, 你是用最新版的盈再表嗎?為什麼我的ZBH盈再表跑出來的跟你的差很大?
頂部
Curry
同學




UID 66927
精華 0
積分 0
帖子 1522
閱讀權限 99
註冊 2017-2-14
用戶註冊天數 2599
用戶失蹤天數 408

118.163.167.118
發表於 2018-2-8 10:38  資料 私人訊息 
lounge19
麻煩您先看先前討論:這波美股修正,最想買的股票會是哪一隻
這樣有看到不同了?
若真的還是看不出來再Q一下!
頂部
jaynd
同學




UID 72314
精華 0
積分 0
帖子 46
閱讀權限 99
註冊 2018-3-6
用戶註冊天數 2214
用戶失蹤天數 22

76.118.164.182
發表於 2018-8-7 22:21  資料 私人訊息 
Xray 大跌revenue and eps beat
revenue up 5% compared to prior year
repurchased 5.4 million shares
不懂為什麼跌
希望之前有在關注的同學可以找到好的入點
頂部
須彌芥子
同學




UID 66841
精華 0
積分 0
帖子 40
閱讀權限 99
註冊 2017-1-23
用戶註冊天數 2621
用戶失蹤天數 325

123.193.176.135
發表於 2018-8-7 23:11  資料 私人訊息 
頂部
Raimu
同學




UID 292
精華 0
積分 0
帖子 672
閱讀權限 99
註冊 2011-4-1
用戶註冊天數 4745
用戶失蹤天數 1060

49.159.171.10
發表於 2018-8-7 23:28  資料 私人訊息 
奇怪
為什麼XRAY的股數膨脹這麼快
整個ROE都爛掉了
頂部